Abstract
We investigated rubella antibody titer during pregnancy, delivery history, and labor age in 728 pregnant women between January 2013 and December 2013 in Kobe City Medical Center General Hospital. Among 728 pregnant women, women with high antibody titer numbered 534, and women with low antibody titer numbered 194. In total, the rubella antibody prevalence rate in this study was 73.4% and the percentage of pregnant women with low antibody titer was 26.6%. The rubella antibody prevalence rate of 387 primiparous and 341 multiparous women was 72.4% (280) and 74.5% (254), respectively. Their delivery histories were not related to the rubella antibody prevalence rate (P = 0.52), but pregnant women with high antibody titer were significantly older than pregnant women with low antibody titer (P = 0.0002). We started to recommend receiving the post-partum rubella vaccine to 157 pregnant women with low antibody titer from February 2013. One hundred and thirty-six (86.6%) pregnant women with low antibody titer received the postpartum rubella vaccine according to our recommendation. One of the effective measures to prevent future occurrences of Congenital Rubella Syndrome is to aggressively recommend rubella vaccination so that pregnant women with low antibody titer do not miss an opportunity to receive the post-partum vaccination.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
